Phenylketonuria in pediatric neurology practice: A series of 146 cases

Journal of Child Neurology

Volumn 21, Issue 11, 2006, Pages 987-990

  Yalaz, Kalbiye ^a   Vanli, Lale ^b   Yilmaz, Engin ^a   Tokatli, Aysegul ^a   Anlar, Banu ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Turkish Intelligence Foundation   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLALANINE;

AMINO ACID TRANSPORT; ARTICLE; AUTISM; CLINICAL FEATURE; CONTROLLED STUDY; DIET THERAPY; ENVIRONMENTAL FACTOR; FEMALE; GENOTYPE; HUMAN; HYPOREFLEXIA; INFANT; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; MICROCEPHALY; MOTOR RETARDATION; MUSCLE HYPERTONIA; MUSCLE HYPOTONIA; NEWBORN; PHENYLKETONURIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SIBLING; TREATMENT RESPONSE; TREMOR;

AGE FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENTAL RETARDATION; MUSCLE HYPOTONIA; PHENYLKETONURIAS; SIBLINGS;

EID: 33846328681     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738060210111401     Document Type: Article

References (19)

1. Ozalp I, Coskun T, Tokatli A, et al: Newborn phenylketonuria screening in Turkey: At present and organization for future. Turk J Pediatr 2001;43:97-101.
2. Koch RK: Issues in newborn screening for phenylketonuria. Am Fam Physician 1999;60:1462-1466.
3. Ozguc M, Ozalp I, Coskun T, et al: Mutation analysis in Turkish phenylketonuria patients. J Med Genet 1993;30:129-130.
4. Holtzman C, Slazyk WE, Cordero JF, Hannon WH: Descriptive epidemiology of missed cases of phenylketonuria and congenital hypothyroidism. Pediatrics 1986;78:553-558.
5. Khazipov R, Sirota A, Leinekugel X, et al: Early motor activity drives spindle bursts in the developing somatosensory cortex. Nature 2004; 432:758-761.
6. Nagatsu T, Ichinose H: Regulation of pteridine-requiring enzymes by the cofactor tetrahydrobiopterin. Mol Neurobiol 1999;19:79-96.
7. Brenton DP, Pietz J: Adult care in phenylketonuria and hyperphenylalaninaemia: The relevance of neurological abnormalities. Eur J Pediatr 2000;159 (Suppl 2):S114-S120.
8. Azen C, Koch R, Friedman E, et al: Summary of findings from the United States Collaborative Study of children treated for phenylketonuria. Eur J Pediatr 1996;155 (Suppl 1):S29-S32.
9. Waisbren SE, Brown MJ, de Sonneville LM, Levy HL: Review of neuropsychological functioning in treated phenylketonuria: An information processing approach. Acta Paediatr 1994;407: 98-103.
10. Allen RJ, Gibson RM: Phenylketonuria with normal intelligence. Am J Dis Child 1961;102:115-122.
11. Okano Y, Eisensmith RC, Guttler F, et al: Molecular basis of phenotypic heterogeneity in phenylketonuria. N Engl J Med 1991; 324:1232-1238.
12. Özalp I, Coskun T, Ozguc A, et al: Genetic and neurological evaluation of untreated and late-treated patients with phenylketonuria. J Inherit Metab Dis 1994;17:371.
13. Andersen AE, Avins L: Lower brain phenylalanine levels by giving other large neutral amino acids. Arch Neurol 1976;33:684-686.
14. Kaufman S: Some factors relevant to the consideration of a possible alternative treatment for classical phenylketonuria. J Inherit Metab Dis 1998;21:4-19.
15. Ramus SJ, Forrest SM, Pitt DD, Cotton RG: Genotype and intellectual phenotype in untreated phenylketonuria patients. Pediatr Res 1999; 45:474-481.
16. Weglage J, Wiedermann D, Denecke J, et al: Individual blood-brain barrier phenylalanine transport determines clinical outcome in phenylketonuria. Ann Neurol 2001;50:463-467.
17. Holtzman NA, Meek AG, Mellits ED, Kallman CH: Neonatal screening for phenylketonuria 3. Altered sex ratio; extent and possible causes. J Pediatr 1974;85:175-181.
18. Leuzzi V, Bianchi MC, Tosetti M, et al: Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria. J Inherit Metab Dis 2000;23:563-570.
19. Black H: Newborn screening report sparks debate in USA. Lancet 2005;365:1453-1454.